Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-12 · accession 0001127602-24-018724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-12 | DNA | Hannan Kathy Hopinkah | Dir | M - OptEx | — | +105.3K | 167.2K | +170% | — |
| DM | 2024-06-14 | 2024-06-13 | DNA | Hannan Kathy Hopinkah | Dir | A - Grant | $0.00 | +1.00M | 571.4K | New | $0 |
| D | 2024-06-14 | 2024-06-12 | DNA | Hannan Kathy Hopinkah | Dir | M - OptEx | — | -105.3K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-12 | M | A | 105,263 | — | 167,249 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 2 | Derivative | Restricted Stock Units | 2024-06-13 | A | A | 432,900 | $0.00 | 432,900 | D | $0.00 · — to — | 432,900 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date. |
| 3 | Derivative | Restricted Stock Units | 2024-06-12 | M | D | 105,263 | — | 0 | D | $0.00 · — to — | 105,263 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F2) In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 16, 2023 vested in full in Class A shares on June 12, 2024, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. |
| 4 | Derivative | Stock Option | 2024-06-13 | A | A | 571,428 | $0.00 | 571,428 | D | $0.46 · — to 2034-06-13 | 571,428 Class A Common Stock | (F4) In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000. (F3) The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date. |